You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Russia

Mar 2012

Price: US$2,400

About this Report

EXECUTIVE SUMMARY

Optimistic year despite negative regulatory settings

The pace of growth in consumer health increased in 2011, with hopes of further growth. After a moderate performance in 2010, it saw stronger development in 2011. Manufacturers and chemists/pharmacies, obliged to meet new regulations, had to come through business process optimisation. Product portfolios were carefully revised, and the product quality improved. Consumers, who saw more stability in the economy, widened the range of health and beauty products they bought. At the same time consumers remained value-oriented, seeking the best price for higher quality and safe products.

Basis for future development under construction

In 2011 the consequences of the government’s industry development strategy Pharma 2020 were obvious. Governors of regions such as Moscow, St Petersburg, Yaroslavl and Kaluga focused on the development of pharmaceutical clusters in their territories. Some international players announced their decision to localise different stages of the process in Russia – from scientific laboratories to manufacturing facilities. Work was started on the construction of factories for leading international pharmacy giants.

Higher-priced products regain their attractiveness

In 2011 international companies fought back against the share gains achieved by domestic companies during the period of economic slowdown, as the economy showed signs of recovery. Smaller domestic players have competitive prices, which was an advantage in the middle of the review period. However, after retail mark-ups for products from the Vital and Essential Drugs List became regulated, low price became a disadvantage, as retailers facing decreased margins had to sell higher-priced products. In this situation, higher-priced, well-promoted products saw better sales than their lower-priced competitors, manufactured by domestic companies.

Changes in pharmacy retail continue

The end of the review period saw chemists/pharmacies suffering from decreasing margins. Increased rivalry, tighter taxation and regulation requirements made them seek operational efficiency and image improvement. Larger players such as Rigla, 36.6 and others announced the development of a new format – pharmacy discounters. Another direction of this development was the growing scale of online operations, which was a success in cities with developed internet infrastructure and busy lifestyles.

Growth in per capita consumption to support stable market development

The trend of economic recovery observed at the end of the review period is threatened by the expected global economic downturn at the beginning of the forecast period. However, consumer health in Russia passed through significant turbulence at the end of the review period, and is expected to see continuous stable development in the forecast period. Consumption in Russia is much lower than in developed markets; thus this potential is expected to be exploited by companies over the forecast period. The rising disposable incomes of different social groups and an increasing number of health-concerned consumers will accelerate this development. Regions of Russia are expected to provide greater input to growth than capital cities, due to lower maturity.


Samples (FAQs about samples):

doc_pdf.png Sample Consumer Health Market Research Report

doc_excel_table.png Sample Consumer Health Data

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Russia with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Russia, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Russia for free:

The Consumer Health in Russia market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Russia?
  • What are the major brands in Russia?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Table of Contents

Table of Contents

Consumer Health in Russia - Industry Overview

EXECUTIVE SUMMARY

Optimistic year despite negative regulatory settings

Basis for future development under construction

Higher-priced products regain their attractiveness

Changes in pharmacy retail continue

Growth in per capita consumption to support stable market development

KEY TRENDS AND DEVELOPMENTS

Russian government puts further effort into reducing dependence on imports

Ban on OTC drug precursors

Pharmacy retail enters a new stage of development

Healthier lifestyles drive sales of vitamins and dietary supplements

Russia fights counterfeit drugs

CITY KEY TRENDS AND DEVELOPMENTS

Moscow

St Petersburg

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  • Table 2 Life Expectancy at Birth 2006-2011

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2006-2011
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2006-2011
  • Table 5 Sales of Consumer Health by City: Value 2006-2011
  • Table 6 Sales of Consumer Health by City: % Value Growth 2006-2011
  • Table 7 Consumer Health Company Shares 2007-2011
  • Table 8 Consumer Health Brand Shares 2008-2011
  • Table 9 Penetration of Private Label by Category 2006-2011
  • Table 10 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  • Table 11 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
  • Table 12 Forecast Sales of Consumer Health by Category: Value 2011-2016
  • Table 13 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
  • Table 14 Forecast Sales of Consumer Health by City: Value 2011-2016
  • Table 15 Forecast Sales of Consumer Health by City: % Value Growth 2011-2016

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventative medicine

Switches

DEFINITIONS

SOURCES

  • Summary 1 Research Sources

Consumer Health in Russia - Company Profiles

Akrikhin OAO in Consumer Health (Russia)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 4 Akrikhin OAO: Competitive Position 2011

Berlin Chemie Russia in Consumer Health (Russia)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 6 Berlin Chemie Russia: Competitive Position 2011

Evalar ZAO in Consumer Health (Russia)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 8 Evalar ZAO: Competitive Position 2011

Ferrosan Consumer Health OOO in Consumer Health (Russia)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 10 Ferrosan Consumer Health OOO: Competitive Position 2011

Novartis Consumer Health OOO in Consumer Health (Russia)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 12 Novartis Consumer Health OOO: Competitive Position 2011

Nycomed Russia-CIS in Consumer Health (Russia)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 14 Nycomed Russia-CIS: Competitive Position 2011

Pharmstandart OAO in Consumer Health (Russia)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 17 Pharmstandart OAO: Competitive Position 2011

Sanofi-Aventis Russia in Consumer Health (Russia)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 19 Sanofi-Aventis Russia: Competitive Position 2011

Unipharm Russia in Consumer Health (Russia)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 21 Unipharm Russia: Competitive Position 2011

Veropharm OAO in Consumer Health (Russia)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 24 Veropharm OAO: Competitive Position 2011

Adult Mouth Care in Russia - Category Analysis

HEADLINES

TRENDS

  • In 2011 pharmacy retailers continued to suffer from price regulation. This resulted in more efforts made to develop categories containing a few or no drugs from the Vital and Essential Drugs List. Adult mouth care benefited from this due to increased distribution of these products. Wider availability of such products supported 13% current value growth in 2011.

SWITCHES

COMPETITIVE LANDSCAPE

  • Unique Pharmaceutical Laboratories remained the leader in adult mouth care in 2011, although its value share continued to decrease. In 2011 it decreased by three percentage points to 30%. Its Metrogyl Denta brand remained popular, but after marketing support weakened and brand awareness reached high rates, the brand’s sales stopped growing in 2010. This led to a value share decrease.

PROSPECTS

  • Although adult mouth care saw strong growth in the review period, it remained a relatively small category with a limited number of products available. Further development of the category is expected to be driven by new product launches. Another driver will be the spread of knowledge regarding modern OTC ways to treat problems with gums or breath. The moderate performance expected for the Russian economy in the forecast period makes it very likely that consumers will continue to reduce unnecessary spending. This will support the preference of consumers to purchase OTC adult mouth care products to prevent serious problems leading to spending on clinical treatment.

CATEGORY DATA

  • Table 16 Sales of Adult Mouth Care: Value 2006-2011
  • Table 17 Sales of Adult Mouth Care: % Value Growth 2006-2011
  • Table 18 Adult Mouth Care Company Shares by Value 2007-2011
  • Table 19 Adult Mouth Care Brand Shares by Value 2008-2011
  • Table 20 Forecast Sales of Adult Mouth Care: Value 2011-2016
  • Table 21 Forecast Sales of Adult Mouth Care: % Value Growth 2011-2016

Analgesics in Russia - Category Analysis

HEADLINES

TRENDS

  • In 2011 players in analgesics were concerned by the press coverage of a new government initiative to restrict sales of drugs with a reputation of being used by drug addicts. According to the legislation, analgesics which were known to be used as precursors for drugs which cause addiction had to be banned. Discussion was also around drugs potentially having a harmful effect on consumers’ health in the case of being consumed in amounts exceeding the recommended dosage. In the first instance this regulation was expected to ban OTC sales of brands such as Pentalgin-N, Nurofen Plus, Kaffetin and Solpadeine. Journalists caused a fuss, spreading different interpretations of the vague information to consumers. This led to wide discussion regarding the sense of such a ban in the press. The implementation of prescription sales of codeine-containing drugs was postponed from 1 May 2011 to 1 June 2012.

SWITCHES

COMPETITIVE LANDSCAPE

  • After a turbulent 2010, when many manufacturers suffered from unexpected regulation changes, 2011 was a more stable year, with a more predictive market. However, low consumer optimism led to more selective consumer behaviour. Pharmstandart benefited from this, offering reliable, attractive products in different packs for a reasonable price. The sales of the company, with its flagship brand Pentalgin, accounted for a 16% value share, reaching Rb2,669 million. Reckitt Benckiser Healthcare held second position, also with a 16% value share. Its good image, customer loyalty and active marketing campaigns determined the success of its flagship brands Nurofen and Nurofen Ultra-Cap. Berlin Chemie Russia held a 6% share with its strong Fastum Gel brand.

PROSPECTS

  • During the first years of the forecast period analgesics is expected to see a new wave of turbulence caused by government pricing controls and a ban on codeine-containing drugs. Manufacturers will be forced to come up with new ways to overcome the negative effects of price controls, leading to decreasing margins due to increasing competitiveness and the tightening economic environment. This will lead to new sub-brands and the launch of new pack types, and new formulae which do not contain particular ingredients.

CATEGORY DATA

  • Table 22 Sales of Analgesics by Category: Value 2006-2011
  • Table 23 Sales of Analgesics by Category: % Value Growth 2006-2011
  • Table 24 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2006-2011
  • Table 25 Analgesics Company Shares by Value 2007-2011
  • Table 26 Analgesics Brand Shares by Value 2008-2011
  • Table 27 Forecast Sales of Analgesics by Category: Value 2011-2016
  • Table 28 Forecast Sales of Analgesics by Category: % Value Growth 2011-2016

Calming and Sleeping in Russia - Category Analysis

HEADLINES

TRENDS

  • 2011 became the year when the optimistic view for the prospects of the Russian economy switched to being more pessimistic. In 2010 companies which were reducing office staff returned to recruiting, and the number of office workers increased. However, 2011 brought new challenges. The global economy revealed strong signs of instability, which reflected in the motivations and perceptions of people in Russia. Working in settings of high uncertainty and constant stress, people were looking for a means to reduce the negative effects of stress. Calming and sleeping products, which proved to be a good option to reduce stress, experienced continued demand.

SWITCHES

COMPETITIVE LANDSCAPE

  • In 2011 Pharmstandart led calming and sleeping with a 28% value share. Its brand Afobazol became the best-selling brand in the category in 2011. Its sales increased by 143%, and it reached a 24% value share. The product had very strong marketing support and a competitive price. Its gentle and safe effect was a good option for people looking for a calming remedy to reduce everyday work stress.

PROSPECTS

  • The number of people using OTC calming and sleeping products is likely to increase in the future. However, growth is not expected to be very strong, as Russians are traditionally careful with everything related to tranquillisation. As many working people face constant stress, remedies helping to overcome its consequences, such as anxiety, are expected to experience growing demand. People understanding the importance of maintaining high productivity pay attention to any sedative side effects and the compatibility of drugs with stimulators such as coffee. The forecast period is expected to see the abundant development of new generation products which meet the growing requirements of modern consumers.

CATEGORY DATA

  • Table 29 Sales of Calming and Sleeping: Value 2006-2011
  • Table 30 Sales of Calming and Sleeping: % Value Growth 2006-2011
  • Table 31 Calming and Sleeping Company Shares by Value 2007-2011
  • Table 32 Calming and Sleeping Brand Shares by Value 2008-2011
  • Table 33 Forecast Sales of Calming and Sleeping: Value 2011-2016
  • Table 34 Forecast Sales of Calming and Sleeping: % Value Growth 2011-2016

Cough, Cold and Allergy (Hay Fever) Remedies in Russia - Category Analysis

HEADLINES

TRENDS

  • The calm situation in cough, cold and allergy remedies, caused by the absence of any extraordinary epidemics of flu or other viral infections in 2011, was broken by new government initiatives. In April 2011 it was announced that codeine was to be switched to prescription status from May 2011. However, after consideration of the opinions of market players, the start of a ban on OTC sales of codeine-containing drugs was moved to 1 June 2012. The Terpinkod brand fell under this legislation.

SWITCHES

COMPETITIVE LANDSCAPE

  • Novartis Consumer Health held the largest value share of 14% in cough, cold and allergy remedies in 2011. The second largest player became Johnson & Johnson. Its value share increased from 4% in 2010 to 6% in 2011 after the brands Doktor Mom and Rinza were acquired by the company in 2011. Pharmstandart held third position with a 6% value share.

PROSPECTS

  • Cough, cold and allergy remedies is expected to see growth in the forecast period due to more and more Russians switching from traditional treatments used by their grandparents to more efficient treatments available in pharmacies. The process of widening the consumer base will interfere with competition from antiviral drugs and the back to traditional remedies trend.

CATEGORY DATA

  • Table 35 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 36 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 37 Sales of Decongestants by Category: Value 2006-2011
  • Table 38 Sales of Decongestants by Category: % Value Growth 2006-2011
  • Table 39 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 40 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 41 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2007-2011
  • Table 42 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2008-2011
  • Table 43 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2011-2016
  • Table 44 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2011-2016

Digestive Remedies in Russia - Category Analysis

HEADLINES

TRENDS

  • 2011 saw continuous growth of the travel and tourism industry, with Russians more frequently going abroad. The increasing popularity of Asian destinations affected sales of digestive remedies, pushing sales of remedies which allow consumers to prevent indigestion and treat the consequences of eating unfamiliar food.

SWITCHES

COMPETITIVE LANDSCAPE

  • In 2011 digestive remedies was led by Sanofi-Aventis Russia, which accounted for a 15% value share. Its strong portfolio of brands includes No-spa, Maalox, Festal and other brands, which have a long history in the market and are recognised by Russian consumers. Second position was held by Berlin Chemie Russia with an 11% share of value sales. Its Mezym brand accounted for the highest sales in digestive remedies in 2011, reaching Rb2,103 million.

PROSPECTS

  • Consumers are becoming more concerned about the safety of the remedies they take, and taking a systemic approach to addressing the problems they face. In the long term this is likely to affect sales of digestive remedies; providing a short term effect addressing the consequences of ingrained digestion problems is not sufficient. Those remedies which address the primary problem are expected to see an increase in sales in the forecast period. Competition from probiotic supplements and fortified food products is likely to increase during the forecast period.

CATEGORY DATA

  • Table 45 Sales of Digestive Remedies by Category: Value 2006-2011
  • Table 46 Sales of Digestive Remedies by Category: % Value Growth 2006-2011
  • Table 47 Digestive Remedies Company Shares by Value 2007-2011
  • Table 48 Digestive Remedies Brand Shares by Value 2008-2011
  • Table 49 Forecast Sales of Digestive Remedies by Category: Value 2011-2016
  • Table 50 Forecast Sales of Digestive Remedies by Category: % Value Growth 2011-2016

Ear Care in Russia - Category Analysis

HEADLINES

TRENDS

  • Ear problems are often faced by small children. The review period saw the growth of the birth rate, supported by government policy aimed at supporting families having children. The population aged 0-4 years increased by 18% between 2006 and 2011. Another supportive factor was the growing number of parents relying on OTC remedies available in pharmacies, rather than on traditional medicines and methods of treatment advised by their grandmothers. Both factors supported sales of ear care products in 2011.

SWITCHES

COMPETITIVE LANDSCAPE

  • Otipax by Laboratories Biocodex led ear care in 2011 with a value share of 32%. Pharmstandart with its Otinum brand held second place with a 29% value share. Paediatricians and ENT doctors usually recommend either Otinum or Otipax, or both, to let patients make their own purchasing decision. Otipax, known as more gentle medicine, became the choice of parents looking for a safer treatment for their children.

PROSPECTS

  • Ear care is expected to see moderate growth during the forecast period, with a constant value CAGR of 3%. Rising incomes and the expected continuous growth in the birth rate are expected to provide a background for the development of the category. The recommendations of professionals and the growing number of people switching from traditional treatments towards modern remedies available through pharmacy chains will support growth.

CATEGORY DATA

  • Table 51 Sales of Ear Care: Value 2006-2011
  • Table 52 Sales of Ear Care: % Value Growth 2006-2011
  • Table 53 Ear Care Company Shares by Value 2007-2011
  • Table 54 Ear Care Brand Shares by Value 2008-2011
  • Table 55 Forecast Sales of Ear Care: Value 2011-2016
  • Table 56 Forecast Sales of Ear Care: % Value Growth 2011-2016

Emergency Contraception in Russia - Category Analysis

TRENDS

  • All drugs classified as emergency contraception remained Rx in Russia in 2011. The long list of side effects and the hormonal nature of these products prevented regulators from changing their status. These Rx products are known for a wide amount of UTC sales.

Eye Care in Russia - Category Analysis

HEADLINES

TRENDS

  • Slight economic growth started in 2010, which continued in 2011, resulting in unemployment rates decreasing to around the pre-crisis level. The spread of information on eye problems, and the growing availability of modern formats of pharmacies led to the growing penetration of eye care products.

SWITCHES

COMPETITIVE LANDSCAPE

  • Johnson & Johnson led eye care in 2011 with a 29% value share. Santen held second place with a 21% value share. Johnson & Johnson continued to benefit from the strong brand Visine, which became a popular recommendation for people facing minor eye problems, and was the first stop for people looking for remedies to fight eye-related problems for the first time.

PROSPECTS

  • In the forecast period consumers are expected to pay increasing attention to their eye health. Increasing stress related to long hours spent in front of a computer and constant use of different mobile devices is expected to provide the background for eye health concerns amongst customers. The spread of knowledge about available remedies and a desire to prevent serious disease rather than to fight the consequences will determine the preference for standard eye care products. However, technology changes, with more and more places of work equipped with less harmful monitors, and many devices providing high-quality graphics which are less stressful for the eyes, will help people not to overstress their eyes. The greater spread of vitamins and dietary supplements which aim to solve the same problem as eye care products will create indirect competition for these products. Eye care is expected to see a constant value CAGR of 3% in the forecast period.

CATEGORY DATA

  • Table 57 Sales of Eye Care by Category: Value 2006-2011
  • Table 58 Sales of Eye Care by Category: % Value Growth 2006-2011
  • Table 59 Standard Eye Care by Format: % Value Breakdown 2007-2011
  • Table 60 Standard Eye Care by Positioning: % Value Breakdown 2007-2011
  • Table 61 Eye Care Company Shares by Value 2007-2011
  • Table 62 Eye Care Brand Shares by Value 2008-2011
  • Table 63 Forecast Sales of Eye Care by Category: Value 2011-2016
  • Table 64 Forecast Sales of Eye Care by Category: % Value Growth 2011-2016

Herbal/Traditional Products in Russia - Category Analysis

HEADLINES

TRENDS

  • In 2011 the mass media in Russia covered herbal products mostly in terms of discussing the problem of codeine-containing preparations and the effectiveness of dietary supplements sold in the market.

COMPETITIVE LANDSCAPE

  • In 2011 herbal/traditional products remained highly fragmented, with only three companies having value shares of 4-6%. Warner-Lambert Russia led with a 6% value share. Its Halls medicated confectionery brand benefited from wide distribution in grocery retail, and a wide loyal consumer group. The brand has a long history in the market, and a good reputation as an effective preventive cough remedy. The second largest company was Pharmstandart with a 5% value share. Its strong Kodelak brand was criticised for being used by drug addicts to prepare drugs. The third largest company, Evalar, held a 4% share, offering a wide portfolio of OTC products and dietary supplements.

PROSPECTS

  • The forecast period is expected to see the continuous development of herbal/traditional products. Herbal remedies are expected to gain popularity, promoted by large players such as Evalar, Bionorica and other large companies specialising in the marketing of herbal products. Digestive remedies, calming and sleeping and tonics and bottled nutritive drinks are expected to see the continuous development of herbal products, as remedies made from herbal components are believed to be more gentle and harmless. Consumers’ desire to substitute standard medicines will lead to the further development of the herbal range available, even in categories such as cough and cold remedies.

CATEGORY DATA

  • Table 65 Sales of Herbal/Traditional Products: Value 2006-2011
  • Table 66 Sales of Herbal/Traditional Products: % Value Growth 2006-2011
  • Table 67 Herbal/Traditional Products Company Shares 2007-2011
  • Table 68 Herbal/Traditional Products Brand Shares 2008-2011
  • Table 69 Forecast Sales of Herbal/Traditional Products: Value 2011-2016
  • Table 70 Forecast Sales of Herbal/Traditional Products: % Value Growth 2011-2016

Medicated Skin Care in Russia - Category Analysis

HEADLINES

TRENDS

  • Along with the spread of Western cultural values amongst Russian citizens, consumers continued to pay high attention to their appearance and exterior beauty. Improving living standards and established beliefs regarding the way a person with high status should look led to increased spending on remedies which allowed them to solve problems which previously they ignored. The growing availability of private clinics offering consultations with cosmetologists, trichologists and other professionals on a wide range of issues, including skin conditions and ways to treat them, led to growing awareness of the means to solve problems people used to face, but hesitated to start solving. Growth of the internet facilitated the spread of knowledge, helping people to get information regarding problems they would hesitate to discuss face-to-face with anyone.

SWITCHES

COMPETITIVE LANDSCAPE

  • Sandoz led medicated skin care in 2010 due to a dramatic increase in sales of its flagship brand Eczoderil, resulting in the company’s total value share reaching 13%. The leader from 2010, Sagmel, which did not see a strong sales increase, fell to second position with a 10% value share.

PROSPECTS

  • Medicated skin care is expected to continue to develop along with the spread of modern products and increasing living standards. The availability of information on different skin disorders on the internet and the confidentiality of such information sharing will support the growth of the consumer base. The priorities of Russian consumers will continue evolving, with a greater focus being placed on personal beauty and health. This will support the growth of the category.

CATEGORY DATA

  • Table 71 Sales of Medicated Skin Care by Category: Value 2006-2011
  • Table 72 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  • Table 73 Medicated Skin Care Company Shares by Value 2007-2011
  • Table 74 Medicated Skin Care Brand Shares by Value 2008-2011
  • Table 75 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  • Table 76 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016

NRT Smoking Cessation Aids in Russia - Category Analysis

HEADLINES

TRENDS

  • 2011 saw the implementation of the five year concept adopted by the Russian government at the end of 2010. Besides tobacco tax increases, the concept provides the stimulus to organise special zones for smokers, to prevent passive smoking. Restrictions on smoking in public places were announced. Although the consequences were not clearly seen in 2011, this concept could potentially affect all tobacco smokers in Russia. Information, support and restrictions create the possibility of a steady decline in the number of smokers in Russia in the coming five years.

SWITCHES

COMPETITIVE LANDSCAPE

  • Johnson & Johnson dominated NRT smoking cessation aids in Russia in 2011, with a value share of 95%.

PROSPECTS

  • Tightening of the regulations related to tobacco smoking will be the main driver of sales in the forecast period. The concept adopted in 2010 is expected to be implemented, with a ban on smoking in public places, including restaurants and cafeterias, on the cards. There will be a significant increase in cigarette prices due to a gradual tax increase of 30-40%. Restrictions on sales and requirements regarding cigarette packaging design are likely to lead to an increase in the number of people trying to stop smoking. This will be highly beneficial for sales of NRT smoking cessation aids.

CATEGORY INDICATORS

  • Table 77 Number of Smokers by Gender 2006-2011

CATEGORY DATA

  • Table 78 Sales of NRT Smoking Cessation Aids by Category: Value 2006-2011
  • Table 79 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2006-2011
  • Table 80 NRT Gum Flavours: % Value Breakdown 2006-2011
  • Table 81 NRT Smoking Cessation Aids Company Shares by Value 2007-2011
  • Table 82 NRT Smoking Cessation Aids Brand Shares by Value 2008-2011
  • Table 83 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2011-2016
  • Table 84 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2011-2016

OTC Triptans in Russia - Category Analysis

TRENDS

  • In 2011 all drugs classified as triptans remained Rx in Russia. Doctors can prescribe triptans to patients suffering from migraines if this diagnosis is approved. A switch to OTC is not expected, due to the specifics of the product and the known love of Russians for self-medication, whereby they use drugs without a precisely diagnosed illness.

Sports Nutrition in Russia - Category Analysis

HEADLINES

TRENDS

  • Economic recovery led to increased optimism in the Russian market. In 2011 the largest cities saw continuous development of sports and fitness infrastructure, with the state companies and private chains unfreezing their projects after temporary financial difficulties during the economic downturn, and the launch of new projects.

COMPETITIVE LANDSCAPE

  • Multipower Sportsfood led sports nutrition in 2011 with an 18% value share. Its position was achieved due to the popularity of its Multipower brand. It was one of the first sports nutrition brands in the Russian market, and over the years has become beloved by consumers and recommended by professionals. In 2011 its value share declined by half a percentage point due to increased competition from lower-priced brands.

PROSPECTS

  • The popularisation of sports and fitness, supported by government programmes, is expected to continue to influence sales in sports nutrition. The development of fitness centre chains and sports infrastructure in cities and rural areas will lead to a greater number of people participating in sports regularly. Increasing incomes will allow people looking for serious results and a better performance to consume sports nutrition products. The increasing distribution and the widening product range will support the growth of the category in the forecast period.

CATEGORY DATA

  • Table 85 Sales of Sports Nutrition: Value 2006-2011
  • Table 86 Sales of Sports Nutrition: % Value Growth 2006-2011
  • Table 87 Sports Nutrition Company Shares 2007-2011
  • Table 88 Sports Nutrition Brand Shares 2008-2011
  • Table 89 Forecast Sales of Sports Nutrition: Value 2011-2016
  • Table 90 Forecast Sales of Sports Nutrition: % Value Growth 2011-2016

Vitamins and Dietary Supplements in Russia - Category Analysis

HEADLINES

TRENDS

  • 2011 saw a recovery in vitamins and dietary supplements, after the growth rate slowed in 2010. Although the category did not see a significant volume sales increase, growth in value terms recovered to above the growth rate seen in 2009. From the fourth quarter of 2010 pessimism regarding the future economic situation in Russia became less intense, giving reason for optimism, which dominated during the first half of 2011. High oil prices, supported by political crisis in North Africa and the Middle East, provided support for optimism regarding future GDP growth in the second half of 2011. Consumers, feeling certainty in their future incomes, became less concerned about reducing costs, and increased their spending on preparations, allowing them to prevent health problems. Growth of the category was supported by efforts made by the largest manufacturers, such as Evalar and Pharmstandart, to promote their products on television and via other mass media. Another factor was popular talk shows discussing health-related problems on central channels.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • Evalar led vitamins and dietary supplements with a 9% value share in 2011. The company benefited from its strong brand and wide distribution. The company is developing its own pharmacy chain in the key Moscow market. Wide support on television and an established distribution network strongly supported the company’s sales growth. The company has a wide portfolio of products, including large dietary supplements brands like Chernika-forte, Ovesol and Gepatrin and numerous brands with lower value sales.

PROSPECTS

  • The forecast period is expected to see a period of stable growth in vitamins and dietary supplements. The efforts of manufacturers and doctors will constantly widen the consumer base. Penetration of these products remains relatively low in comparison with countries in Western Europe. The country is expected to see economic growth over the forecast period, with Russians’ incomes increasing. The growing economy will be associated with busier lifestyles, with an increasing number of consumers of specific dietary supplements, such as those supporting eye health or facilitating mental activity. Rising income levels will allow people to increase their spending on health and beauty. This process will be facilitated by increasing access to the internet. Active marketing campaigns and the increasing activity of the largest manufacturers will drive the further growth of the category in the forecast period.

CATEGORY DATA

  • Summary 25 Dietary Supplements: Brand Ranking by Positioning 2011
  • Table 91 Sales of Vitamins and Dietary Supplements by Category: Value 2006-2011
  • Table 92 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2006-2011
  • Table 93 Dietary Supplements by Positioning 2006-2011
  • Table 94 Vitamins and Dietary Supplements Company Shares by Value 2007-2011
  • Table 95 Vitamins and Dietary Supplements Brand Shares by Value 2008-2011
  • Table 96 Vitamins Brand Shares by Value 2008-2011
  • Table 97 Dietary Supplements Brand Shares by Value 2008-2011
  • Table 98 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2011-2016
  • Table 99 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2011-2016

Weight Management in Russia - Category Analysis

HEADLINES

TRENDS

  • Russia, with a high percentage of the population being overweight as a result of lack of exercise and unbalanced nutrition, remains a market with high growth potential for weight management products. The end of the review period saw the development of the product range and growth of the category, which stopped in 2010 due to economic uncertainty, with customers cutting their expenditure on costly non-essential products.

COMPETITIVE LANDSCAPE

  • Herbalife International RS led weight management in 2011 with a 24% share of value sales. The company is one of the oldest direct sellers in the Russian market, and in 2011 started a reorganisation, aiming to improve its position in the country. Although some people continued to perceive the company in a negative light, its new image benefited from sports team sponsorship and strong information support. High-quality products were the basis for the company increasing its consumer base.

PROSPECTS

  • Over the forecast period there is expected to be an increase in the number of people concerned with excessive weight. In Russia, still only a small proportion of the urban population participates in sports. Lack of exercises and unbalanced eating habits are leading to people becoming overweight. More and more people are expected to opt for weight management products to solve their problems. Efforts by major players and pharmacies will lead to development. Growth will be facilitated by increasing media coverage, growth in incomes and the improved image of the category after regulations were imposed. Domestic players are expected to take further steps to increase their value shares.

CATEGORY DATA

  • Table 100 Sales of Weight Management: Value 2006-2011
  • Table 101 Sales of Weight Management: % Value Growth 2006-2011
  • Table 102 Weight Management Company Shares 2007-2011
  • Table 103 Weight Management Brand Shares 2008-2011
  • Table 104 Forecast Sales of Weight Management: Value 2011-2016
  • Table 105 Forecast Sales of Weight Management: % Value Growth 2011-2016

Wound Care in Russia - Category Analysis

HEADLINES

TRENDS

  • 2011 saw an extended product offering in the mature wound care category. Products produced for years and familiar to all consumers, such as cotton wool, plasters and bandages, dominated. Strong competition led to a decrease in margins and price competition. At the end of the review period the largest manufacturers, which realised the problem, embarked on the reorganisation of their production facilities and the rearrangement of their product portfolios. New players started to offer consumers new solutions for specific problems.

COMPETITIVE LANDSCAPE

  • In 2011 Veropharm remained the leader in wound care with a 28% value share. The company achieved a stable performance after a modest decline seen in 2010/2009. The high proportion of low-cost, low-margin products in its portfolio was the main reason for the moderate performance in 2010. Renovated products in the company’s product portfolio became drivers for its performance in 2011 though the company developed slightly slower than the overall market.

PROSPECTS

  • Wound care is expected to see a constant value CAGR of 1% during the forecast period. Growth in this largely mature category is expected to be driven by the development of new product types. Plasters aimed at preventing water penetration, patches effectively stimulating the regeneration of tissue, and corn plasters, which are not yet widely known in Russia, are expected to widen the consumer base, driving sales. A great deal of effort is being put into the popularisation of sports in Russia. Along with growth in the number of sports areas such as stadiums, sports halls and gyms, demand for elastic bandages for different purposes is also expected to see growth. Traditional wound treatment products are expected to see price competition during the forecast period.

CATEGORY DATA

  • Table 106 Sales of Wound Care by Category: Value 2006-2011
  • Table 107 Sales of Wound Care by Category: % Value Growth 2006-2011
  • Table 108 Wound Care Company Shares by Value 2007-2011
  • Table 109 Wound Care Brand Shares by Value 2008-2011
  • Table 110 Forecast Sales of Wound Care by Category: Value 2011-2016
  • Table 111 Forecast Sales of Wound Care by Category: % Value Growth 2011-2016

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Paediatric Analgesics
            • Paediatric Acetaminophen
            • Paediatric Aspirin
            • Paediatric Combination Products - Analgesics
            • Paediatric Diclofenac
            • Paediatric Dipyrone
            • Paediatric Ibuprofen
            • Paediatric Ketoprofen
            • Paediatric Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Paediatric Cough, Cold and Allergy Remedies
          • Paediatric Allergy Remedies
          • Paediatric Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Paediatric Digestive Remedies
          • Paediatric Diarrhoeal Remedies
          • Paediatric Indigestion and Heartburn Remedies
          • Paediatric Laxatives
          • Paediatric Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Paediatric Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
      • Protein Products
        • Bars
        • Powder
        • RTD
        • Other Protein
      • Non-Protein Products
    • Vitamins and Dietary Supplements
      • Paediatric Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
            • Hawthorn
            • Rosehip
            • Sabelnik
            • Topinambur
        • Non-Herbal Dietary Supplements
          • Calcium Supplements
          • Co-Enzyme Q10
          • Combination Non-Herbal Dietary Supplements
          • Eye Health Supplements
          • Fish Oils
            • Cod Liver Oil
            • Other Fish Oils
          • Glucosamine
          • Mineral Supplements
          • Omega-3-6-9 (Fish and Non-Fish)
          • Probiotic Supplements
          • Protein Powder
          • Royal Jelly
          • Sam-E
          • Other Non-Herbal Dietary Supplements
            • Yeast
            • Other Other Non-Herbal Dietary Supplements
      • Tonics and Bottled Nutritive Drinks
      • Vitamins
        • Multivitamins
        • Single Vitamins
          • Vitamin A
          • Vitamin B
          • Vitamin C
          • Vitamin D
          • Vitamin E
          • Other Single Vitamins
    • Weight Management
      • Meal Replacement Slimming
      • OTC Obesity
      • Slimming Teas
      • Weight Loss Supplements
      • Other Slimming Products
    • Herbal/Traditional Products
      • Herbal/Traditional Analgesics
      • Herbal/Traditional Calming and Sleeping Products
      • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
      • Herbal/Traditional Digestive Remedies
      • Herbal/Traditional Medicated Skin Care
      • Herbal/Traditional Medicinal Teas
      • Herbal/Traditional Smoking Cessation Aids
      • Herbal/Traditional Paediatric Dietary Supplements
      • Herbal/Traditional Dietary Supplements
      • Herbal/Traditional Tonics and Bottled Nutritive Drinks
    • Allergy Care
      • Allergy Eye Care
      • Antihistamines/Allergy Remedies (Systemic)
      • Paediatric Allergy Remedies
      • Topical Allergy Remedies/Antihistamines
    • Paediatric Consumer Health
      • Paediatric Analgesics
        • Paediatric Acetaminophen
        • Paediatric Aspirin
        • Paediatric Combination Products - Analgesics
        • Paediatric Diclofenac
        • Paediatric Dipyrone
        • Paediatric Ibuprofen
        • Paediatric Ketoprofen
        • Paediatric Naproxen
      • Paediatric Cough, Cold and Allergy Remedies
        • Paediatric Allergy Remedies
        • Paediatric Cough/Cold Remedies
      • Paediatric Digestive Remedies
        • Paediatric Diarrhoeal Remedies
        • Paediatric Indigestion and Heartburn Remedies
        • Paediatric Laxatives
        • Paediatric Motion Sickness Remedies
      • Paediatric Medicated Skin Care
      • Nappy (Diaper) Rash Treatments
      • Paediatric Vitamins and Dietary Supplements

Statistics Included

Statistics Included

For each category and subcategory you will receive the following data in Excel format:

From Passport

  • Market sizes
  • Company shares
  • Brand shares
  • Distribution
  • Analysis by format
  • Analysis by positioning
  • Analysis by type
  • Herbal/traditional vs standard
  • Pricing
  • Smoking population - number of adult smokers
  • Smoking prevalence - % of adult population

Market size details:

  • Retail volume
  • Retail volume % growth
  • Retail volume per capita
  • Retail value retail selling price % growth
  • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price % growth
  • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY

Methodology

Methodology

Global insight and local knowledge

With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

Industry specialists

Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

Country and regional analysts

Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

In-country research network

To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

Research Methodology

Our research methods

Each Euromonitor International industry report is based on a core set of research techniques:

Desk research

With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

  • National statistics offices governmental and official sources
  • National and international trade press
  • National and international trade associations
  • Industry study groups and other semi-official sources
  • Company financials and annual reports
  • Broker reports
  • Online databases
  • The financial, business and mainstream press

Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

Store checks

Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

  • Place: We track products in all relevant channels, selective and mass, store and non-store
  • Product: What are innovations in products, pack sizes and formats?
  • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
  • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

Trade survey

Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

Trade surveys allow us to:

  • Fill gaps in available published data per company
  • Generate a consensus view of the size, structure and strategic direction of the category
  • Access year-in-progress data where published sources are out of date
  • Evaluate the experts’ views on current trends and market developments

In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

Company analysis

At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

Forecasts

Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

Data validation

All data is subjected to an exhaustive review process, at country, regional and global levels.

The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

Market analysis

Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

my pages

Want to find out more about this report?

If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!